🎁 Black Friday: up to 50% off of annual plans
NATCO Pharma Limited (BOM:524816)
India flag India · Delayed Price · Currency is INR
817.00
-4.50 (-0.55%)
At close: Nov 20, 2026

NATCO Pharma Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
10,6901,9891,2007041,3191,111
Short-Term Investments
4,48319,25623,69913,2086,6126,488
Cash & Short-Term Investments
15,17321,24524,89913,9127,9317,599
Cash Growth
-52.65%-14.67%78.97%75.41%4.37%-7.07%
Accounts Receivable
8,0348,81212,46611,8898,5616,206
Other Receivables
-8021,045706351545
Receivables
8,1409,71213,60512,6859,0146,855
Inventory
10,0629,8988,4947,9178,0898,620
Prepaid Expenses
-221305289283326
Other Current Assets
8,9749,4475,3975,4324,6861,467
Total Current Assets
42,34950,52352,70040,23530,00324,867
Property, Plant & Equipment
29,92428,39126,57324,35023,03423,084
Long-Term Investments
39,68625,4891,5289598731,044
Goodwill
644630574560552507
Other Intangible Assets
1,8501,9432,0871,3711,326822
Long-Term Deferred Tax Assets
1,9462,326501194--
Other Long-Term Assets
1,5891,4352,3451,394786767
Total Assets
117,988110,73786,30869,06356,57451,091

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
4,2444,0932,7492,3552,6381,618
Accrued Expenses
-1,192977843691569
Short-Term Debt
-3,0642,7313,7811,7444,205
Current Portion of Long-Term Debt
10,2673,000----
Current Portion of Leases
39331727635
Current Income Taxes Payable
58857903231019
Other Current Liabilities
4,3655,4222,1712,3991,651668
Total Current Liabilities
19,50316,8099,4359,7286,8317,104
Long-Term Debt
-1,000----
Long-Term Leases
284246531180
Pension & Post-Retirement Benefits
-91181266468574
Long-Term Deferred Tax Liabilities
2222124301
Other Long-Term Liabilities
808582521483402396
Total Liabilities
20,34118,52610,18510,5327,8368,455

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
358358358358365365
Additional Paid-In Capital
-12,01912,01912,01914,06514,078
Retained Earnings
-76,48163,06145,25233,51827,261
Comprehensive Income & Other
97,2893,353632902790932
Total Common Equity
97,64792,21176,07058,53148,73842,636
Minority Interest
--53---
Shareholders' Equity
97,64792,21176,12358,53148,73842,636
Total Liabilities & Equity
117,988110,73786,30869,06356,57451,091

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
10,3347,1392,7943,8611,7614,320
Net Cash (Debt)
4,83914,10622,10510,0516,1703,279
Net Cash Growth
-83.56%-36.19%119.93%62.90%88.17%-38.57%
Net Cash Per Share
27.0278.76123.4256.0033.8017.98
Filing Date Shares Outstanding
179.13179.11179.11179.11182.47182.52
Total Common Shares Outstanding
179.13179.11179.11179.11182.47182.52
Working Capital
22,84633,71443,26530,50723,17217,763
Book Value Per Share
545.11514.83424.71326.79267.10233.60
Tangible Book Value
95,15389,63873,40956,60046,86041,307
Tangible Book Value Per Share
531.18500.46409.85316.01256.81226.31
Land
-6,0705,2653,6922,8552,641
Buildings
-11,32611,09011,08010,5939,734
Machinery
-20,56719,48518,34017,61616,798
Construction In Progress
-2,9372,2541,3736431,295